Bizarre Patents
A forehead support apparatus for resting a standing users forehead against a wall above a bathroom commode or urinal or beneath a showerhead.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8115000 | Pyrazine derivatives and uses thereof in renal monitoring The present invention relates to pyrazine derivatives such as those represented by Formulas (I) and (II) below. X1 to X4 of the compounds of Formulas I and II may be characterized as electron withdrawing groups. In contrast, Y1 to Y | 02/14/2012 |
| 7807834 | Capped pyrazinoylguanidine sodium channel blockers The present invention relates to group of pyrazinoylguanidine compounds useful as sodium channel blockers. The compounds may be used to promote promoting hydration of mucosal surfaces. ... | 10/05/2010 |
| 7388013 | Capped pyrazinoylguanidine sodium channel blockers The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers. ... | 06/17/2008 |
| 7375107 | Alaphatic pyrazinoylguanidine sodium channel blockers The present invention provides compound represented by formula (I): where the structural variables are defined herein. The compounds function as sodium channel blockers and may be used to treat a variety of respiratory cond... | 05/20/2008 |
| 7317013 | Cyclic pyrazinoylguanidine sodium channel blockers The present invention provides sodium channel blockers represented by formula (I): where the structural variables are defined herein. The compounds of the present invention may be used for treating a variety of c... | 01/08/2008 |
| 7273868 | Pyrazine derivatives 1. A cyclic compound of the formula (I) or a pharmacologically acceptable salt thereof, wherein X is ═CH— or ═N—, Y is —NH—, —NR4—, —S—, ... | 09/25/2007 |
| 7265115 | Diazabicyclic CNS active agents Compounds of formula I: or pharmaceutically acceptable salts thereof, are useful for controlling synaptic transmission in mammals. ... | 09/04/2007 |
| 7247637 | Capped pyrazinoylguanidine sodium channel blockers The present invention relates to a compound represented by formula (I): where the structural variables are as defined herein. The compound is useful for promoting hydration of mucosal surfaces. ... | 07/24/2007 |
| 7247636 | Phenolic guanidine sodium channel blockers The present invention relates to sodium channel blockers. The present invention also relates to a variety of methods of treatment using these sodium channel blockers. ... | 07/24/2007 |
| 7232821 | (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein A, R1, R2, Rx, R8, R9 and n are as defined in the specification, a proc... | 06/19/2007 |
| 7105522 | HIV inhibiting pyrazinone derivatives This invention concerns a compound of formula a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochemically isomeric form thereof, wherein R1 is hydrogen, hydroxy, c... | 09/12/2006 |
| 7064129 | Capped pyrazinoylguanidine sodium channel blockers Compounds are provided which are represented by the formula: where the structural variables are defined herein. The present invention also includes a variety of methods of treatment using these inventive sodium c... | 06/20/2006 |
| 6964965 | Substituted pyrazine derivatives The present invention provides substituted pyrazine derivatives of Formula I, that are CRF1 receptor antagonists, including human CRF1 receptors. This invention also relates to use of compounds of... | 11/15/2005 |
| 6949556 | Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical agents The present invention relates to compounds of general formula (I), wherein R1-R4 have the meanings given in the specification, A is CH2, CHOH or CH—(C1-C3-alkyl), B and C a... | 09/27/2005 |
| 6903105 | Sodium channel blockers The present invention relates to pyrazinoylguanidine compounds represented by formula (I): where at least one of R3 and R4 is a group represented by formula (A): | 06/07/2005 |
| 6858614 | Phenolic guanidine sodium channel blockers The present invention relates to compounds represented by formula (I): in which at least one of R3 and R4 is a group represented by formula (A): whe... | 02/22/2005 |
| 6858615 | Phenyl guanidine sodium channel blockers The present invention relates to a compound represented by formula (I): in which at least one of R3 and R4 is a group represented by formula (A): wh... | 02/22/2005 |
| 6833370 | Heterocycle substituted aminoazacycles useful as central nervous system agents Heterocyclic substituted aminoazacyclic compounds of formula I Z—R3 I, wherein Z is a defined aminoazacycle and R3 is a defined heterocycle moiety, pharmaceutical compositions of these compounds, and use of said comp... | 12/21/2004 |
| 6828338 | Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade The present invention relates to compounds, and prodrugs thereof, composition and methods useful for preventing and treating thrombotic conditions in mammals. The compounds of the present invention, and prodrugs thereof, selectively inhibit certain proteases of the ... | 12/07/2004 |
| 6797709 | Aromatic nitrogen-containing 6-membered cyclic compounds An aromatic nitrogen-containing 6-membered cyclic compound of the formula (I): wherein Ring A is a substituted or unsubstituted nitrogen-containing heterocyclic group; R1 is a substituted or unsubstituted lowe... | 09/28/2004 |
| 6797706 | Heterocyclecarboxamide derivative A nitrogen-containing six-membered heterocyclic compound having substituents —X—A—R3, —N(R1)-(Ph substituted by R2), and —CONH2, a salt thereof, a prodrug thereof, and a Syk inhibitor containing the same as an ac... | 09/28/2004 |
| 6765093 | Couplers for use in oxidative hair dyeing Couplers for hair coloring compositions for oxidative dyeing of hair are compounds of the formula (1): where R1 and R2 are each individually selected from a hydrogen atom, a C1 to C3... | 07/20/2004 |
| 6693121 | Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade The invention relates to polycyclic aryl and heteroaryl substituted 4-pyridone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention... | 02/17/2004 |
| 6667342 | Benzenesulfonamide-derivatives and their use as medicaments Compounds of formula (I), pharmaceutically acceptable salts or in vivo hydrolysable esters thereof, wherein: Ring X is phenyl or a six membered heteroaryl ring containing one or two ring nitrogens where said nitrogens are optionally oxidised to form the N... | 12/23/2003 |
| 6649613 | Diacylhydrazine derivatives Diacylhydrazine derivatives of general formula (I) ##STR1## wherein X, Y, Z, R1, 2 and R3 are as defined herein, and their physiologically acceptable salts or solvates thereof, are integrin inhibitors and can be used to co... | 11/18/2003 |
| 6624180 | Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade The present invention relates to compounds, and prodrugs thereof, composition and methods useful for preventing and treating thrombotic conditions in mammals. The compounds of the present invention, and prodrugs thereof, selectively inhibit certain protea... | 09/23/2003 |
| 6586459 | Antithrombotic agents This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well a... | 07/01/2003 |
| 6583173 | Antithrombotic agents This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well a... | 06/24/2003 |
| 6569860 | Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as IP antagonists This invention relates to compounds which are IP receptor antagonists and which are represented by Formula (I): ##STR1## wherein G2 is a heteroaryl group containing one or two nitrogen atoms substituted with a carboxylic acid group, said hetero... | 05/27/2003 |
| 6552025 | Diimino-piperazine derivatives for use as modulators of cell regulation Compositions, methods of use, isolation and biosynthesis of diimino-piperazine derivatives useful for the modification of sphingolipid metabolism and other biological functions are described. The preferred derivative is 2,6-bis-(ω-aminobutyl)-3,5-diimino... | 04/22/2003 |
| 6544997 | 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders The present invention of compounds of formula (I) ##STR1## a stereochemically isomeric form thereof, an N-oxide form thereof or a pharmaceutically acceptable acid addition salt thereof, --R1 --R2 -- is a bivalent radical of formula w... | 04/08/2003 |
| 6503909 | Pyrazine compounds A compound of formula (I) wherein R1 is phenyl substituted by one or more halogen atoms; R2 is --NH2 ; R3 is --NH2 or hydrogen; R4 is --CXNRa Rb, --CXNH--(CH2) | 01/07/2003 |
| 6313151 | Antithrombotic agents This application relates to a compound of formula (I), a pharmaceutically acceptable salt of the compound, or a prodrug thereof, as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its... | 11/06/2001 |
| 6271372 | Process for the preparation of arylamides of heteroaromatic carboxylic acids A process for the preparation of arylamides of heteroaromatic carboxylic acids of the formula: ##STR1## in which each An is nitrogen or CRn (n=1 to 5), with the proviso that at least one of the ring members is nitrogen and that two n... | 08/07/2001 |
| 6204273 | 16-substituted-4-aza-androstane 5--reductase isozyme 1 inhibitors Compounds of the Formula I ##STR1## are inhibitors of the 5-reductase 1 isozyme, and are useful alone, or in combination with a 5-reductase 2 inhibitor, for the treatment of androgenic sensitive disorders such as acne vulgaris, seborrhea, fe... | 03/20/2001 |
| 6200984 | Naphtho-imidazo pyridine derivatives useful in treating central nervous system disorders A compound of the general formula I: ##STR1## is disclosed as useful in treating disorders of the central nervous system. Pharmaceutical compositions, processes for preparing the compounds and methods of treatment are also disclosed.... | 03/13/2001 |
| 6191160 | Spiro-indolines as Y5 receptor antagonists Compounds of the general structural formula I ##STR1## are selective NPY Y5 receptor antagonists. The compounds and compositions of the present invention are useful in the treatment of obesity and complications associated therewith.... | 02/20/2001 |
| 6066650 | Inhibitors of microsomal triglyceride transfer protein and method Compounds are provided which inhibit microsomal triglyceride transfer protein and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases. The compounds have the structure ##STR1## wherein R1 to R7 | 05/23/2000 |
| 6013666 | Oxirane carboxylic acid derivative and its manufacturing method This invention relates to a novel oxirane carboxylic acid derivative and thereof manufacturing method. Based on thereof mechanism to inhibit the CPT I, oxirane carboxylic acid derivative of this invention has blood glucose lowering effects so that the der... | 01/11/2000 |
| 5969138 | Pyrrolidinone derivatives Since a compound represented by general formula (1), its pharmaceutically acceptable salt and a hydrate of the pharmaceutically acceptable salt have high antipsychotic activity, they may be used as an active ingredient for preparation of an antipsychotic.... | 10/19/1999 |
